Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

The diagnostic utility of cardiac biomarkers in dialysis patients.

Wang AY, Wai-Kei Lam C.

Semin Dial. 2012 Jul;25(4):388-96. doi: 10.1111/j.1525-139X.2012.01099.x. Epub 2012 Jul 2. Review.

PMID:
22748194
2.

Use of cardiac biomarkers in end-stage renal disease.

Wang AY, Lai KN.

J Am Soc Nephrol. 2008 Sep;19(9):1643-52. doi: 10.1681/ASN.2008010012. Epub 2008 Mar 5. Review.

3.

Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.

Sommerer C, Giannitsis E, Schwenger V, Zeier M.

Nephron Clin Pract. 2007;107(3):c77-81. Epub 2007 Sep 21. Review.

4.

How does volume status affect BNP and troponin levels as markers of cardiovascular status in peritoneal dialysis?

Garg R, Singh A, Khaja A, Martin A, Aggarwal K.

Congest Heart Fail. 2009 Sep-Oct;15(5):240-4. doi: 10.1111/j.1751-7133.2009.00094.x. Review.

5.

Clinical utility of natriuretic peptides in dialysis patients.

Wang AY.

Semin Dial. 2012 May;25(3):326-33. doi: 10.1111/j.1525-139X.2012.01079.x. Review.

PMID:
22607214
6.

Understanding cardiac biomarkers in end-stage kidney disease: Frequently asked questions and the promise of clinical application.

Roberts MA, Hedley AJ, Ierino FL.

Nephrology (Carlton). 2011 Mar;16(3):251-60. doi: 10.1111/j.1440-1797.2010.01413.x. Review.

PMID:
21342319
7.

[Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].

Bertinchant JP.

Arch Mal Coeur Vaiss. 2004 Sep;97(9):881-8. Review. French.

PMID:
15521481
8.

Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.

Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, Rahman A, Koerbin G, Southcott E, Potter JM.

Intern Med J. 2009 Dec;39(12):812-8. doi: 10.1111/j.1445-5994.2009.01846.x.

PMID:
20233242
9.

Biomarkers for the prediction of mortality and morbidity in patients with renal replacement therapy.

Chaykovska L, Tsuprykov O, Hocher B.

Clin Lab. 2011;57(7-8):455-67. Review.

PMID:
21888009
10.

[Clinical utility of the cardiac markers BNP and NT-proBNP].

Buchner S, Riegger G, Luchner A.

Acta Med Austriaca. 2004;31(4):144-51. Review. German.

PMID:
15732251
11.

Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis.

Ishii J, Nomura M, Okuma T, Minagawa T, Naruse H, Mori Y, Ishikawa T, Kurokawa H, Hirano T, Kondo T, Nagamura Y, Ezaki K, Hishida H.

Clin Chim Acta. 2001 Oct;312(1-2):69-79.

PMID:
11580911
12.

Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.

Chrysochou C, Manzoor S, Wright J, Roberts SA, Wood G, McDowell G, Kalra PA.

Kidney Blood Press Res. 2009;32(5):373-9. doi: 10.1159/000254337. Epub 2009 Nov 3.

13.

Biomarkers in acute cardiovascular disease.

Howie-Esquivel J, White M.

J Cardiovasc Nurs. 2008 Mar-Apr;23(2):124-31. doi: 10.1097/01.JCN.0000305072.49613.92. Review.

PMID:
18382255
14.

The impact of dialysis type on biomarkers for cardiovascular diseases.

Sahinarslan A, Güz G, Mutluay R, Okyay K, Demirtaş C, Paşaoğlu H, Yalçın R.

Turk Kardiyol Dern Ars. 2011 Sep;39(6):456-62. doi: 10.5543/tkda.2011.01289.

15.

Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.

Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Zhang Y, Sanderson JE.

Nephrol Dial Transplant. 2009 Jun;24(6):1962-9. doi: 10.1093/ndt/gfp067. Epub 2009 Feb 23.

PMID:
19237403
16.

Cardiac biomarkers are influenced by dialysis characteristics.

Sommerer C, Heckele S, Schwenger V, Katus HA, Giannitsis E, Zeier M.

Clin Nephrol. 2007 Dec;68(6):392-400.

PMID:
18184522
17.

N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.

Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.

J Am Soc Nephrol. 2007 Jan;18(1):321-30. Epub 2006 Dec 13.

18.

Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ.

Am J Cardiol. 2010 Apr 15;105(8):1065-9. doi: 10.1016/j.amjcard.2009.12.003. Epub 2010 Feb 20.

PMID:
20381654
19.

Supplemental Content

Support Center